RSV Vaccination During Pregnancy: What the Latest Guidance Means for Families

Practical takeaway: In the United States, health officials recommend a single dose of an RSV vaccine during weeks 32 through 36 of pregnancy during RSV season to help protect newborns from severe illness in their first months of life. The goal is to pass protective antibodies from mother to baby before birth.

Respiratory syncytial virus (RSV) is a common respiratory virus. For most healthy adults, it causes cold-like symptoms. But for infants—especially those under 6 months old—it can lead to serious lung infections such as bronchiolitis and pneumonia. RSV is one of the leading reasons babies are hospitalized in the United States.

Why RSV Matters in Obstetrics

Obstetric care increasingly includes infection prevention strategies that protect both pregnant people and their newborns. RSV is a good example. Babies are at highest risk of severe RSV disease in their first few months of life—before they are old enough to build their own immunity.

According to the Centers for Disease Control and Prevention (CDC), thousands of infants are hospitalized each year because of RSV. While most recover, some require oxygen, intensive care, or mechanical ventilation.

What the Vaccine Does

The RSV vaccine approved by the U.S. Food and Drug Administration (FDA) for use during pregnancy is given between 32 and 36 weeks of gestation. The timing is intentional. It allows the pregnant person’s immune system to produce antibodies, which then cross the placenta and help protect the baby after birth.

This approach—called maternal immunization—is already used for other infections, such as influenza and pertussis (whooping cough).

The FDA’s approval was based in part on a large randomized clinical trial published in the New England Journal of Medicine. In that study, maternal vaccination reduced the risk of severe RSV-related lower respiratory tract disease in infants during the first months of life. As with all clinical trials, there were limitations: the study followed infants for a defined time period and may not reflect every real-world setting. But the evidence showed meaningful protection during the highest-risk window—early infancy.

Who Should Consider It?

CDC guidance recommends one dose of the RSV vaccine during weeks 32–36 of pregnancy if the pregnancy overlaps with RSV season, which typically runs from fall through early spring in most of the United States.

It is generally not recommended earlier in pregnancy because the protective antibody transfer works best in the later third trimester.

Some families may also hear about a separate RSV preventive option for infants called a monoclonal antibody injection, which can be given directly to babies. In most cases, either maternal vaccination during pregnancy or infant monoclonal antibody protection is used—talk with your obstetrician and pediatrician about which approach makes sense for your situation.

Safety Considerations

In clinical trials reviewed by the FDA, the vaccine was generally well tolerated. Common side effects were similar to those seen with other adult vaccines, such as injection-site pain, fatigue, or headache.

As with any medical decision during pregnancy, safety is a central concern. Federal agencies, including the CDC and FDA, continue to monitor vaccine safety through post-marketing surveillance systems. Pregnant individuals with specific health concerns, high-risk pregnancies, or prior vaccine reactions should discuss individual risks and benefits with their clinician.

Symptoms of RSV in Infants

Even with preventive measures, it’s important for families to recognize symptoms of RSV in newborns and young infants. These may include:

Rapid or labored breathing
Wheezing
Poor feeding
Unusual sleepiness
Pauses in breathing (in very young infants)

Seek urgent medical care if a baby has trouble breathing, appears blue around the lips or fingernails, or cannot stay awake.

Access and Insurance Coverage

Under current U.S. vaccine policy, most recommended maternal vaccines are covered by private insurance without cost-sharing when administered by an in-network provider. Medicaid coverage may vary slightly by state, but recommended pregnancy vaccines are typically covered.

If cost is a concern, ask your obstetric provider or local health department about coverage options.

What We Still Don’t Know

While trial results are encouraging, researchers are continuing to study:

How long infant protection lasts beyond the first RSV season
How maternal vaccination compares directly with infant monoclonal antibody protection in different settings
How uptake varies across communities and whether disparities in access affect outcomes

Public health experts are also monitoring RSV season patterns, which have shifted somewhat in recent years following the COVID-19 pandemic.

Oral and Overall Health in Pregnancy

Pregnancy is also a time to stay current on routine care, including dental health. While oral health does not directly prevent RSV, untreated dental infections and gum disease can affect overall health during pregnancy. Coordinated prenatal care—including vaccinations, dental care, and chronic disease management—supports healthier outcomes for both parent and baby.

What This Means for Families

If you are in your third trimester during RSV season, talk with your obstetric provider about whether the RSV vaccine is appropriate for you. The decision often depends on timing, medical history, and local RSV activity.

For families welcoming a baby soon, this is one more tool—alongside hand hygiene, avoiding sick contacts, and staying up to date on recommended vaccines—to reduce the risk of serious respiratory illness in early infancy.

As always, individualized medical advice should come from your own healthcare team, who can help you weigh the benefits and any potential risks in the context of your pregnancy.

Sources

Centers for Disease Control and Prevention (CDC) – RSV and maternal vaccination guidance
U.S. Food and Drug Administration (FDA) – RSV vaccine approval information
New England Journal of Medicine – Clinical trial of maternal RSV vaccination